Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from iSpecimen ( (ISPC) ).
iSpecimen Inc. has appointed Yuying Liang as the Chief Financial Officer, enhancing its financial leadership with Liang’s extensive experience in corporate accounting and strategic guidance. The company is expanding its focus on procuring high-demand cancer biospecimens to support cancer research, aiming to form new partnerships and leverage a data-driven approach to meet the growing demand, positioning itself as a preferred provider in the industry.
More about iSpecimen
iSpecimen Inc. is a company that provides an innovative marketplace platform connecting life science researchers with healthcare providers to access high-quality biospecimens. Through its proprietary technology and extensive network, iSpecimen streamlines the procurement process, accelerating medical discoveries and advancing global healthcare.
YTD Price Performance: -70.43%
Average Trading Volume: 446,494
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.85M
See more insights into ISPC stock on TipRanks’ Stock Analysis page.
